RNA Therapy Market Research Report by Technology (Enabled Technologies and Enabling Technologies), by Application (Cancer, Cardiovascular, Genetic Disorders, Infectious Diseases, and Kidney Diseases), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global RNA Therapy Market is expected to grow from USD 862.49 Million in 2019 to USD 2,401.50 Million by the end of 2025.
2. The Global RNA Therapy Market is expected to grow from EUR 770.10 Million in 2019 to EUR 2,105.68 Million by the end of 2025.
3. The Global RNA Therapy Market is expected to grow from GBP 675.89 Million in 2019 to GBP 1,871.95 Million by the end of 2025.
4. The Global RNA Therapy Market is expected to grow from JPY 94,018.26 Million in 2019 to JPY 256,300.90 Million by the end of 2025.
5. The Global RNA Therapy Market is expected to grow from AUD 1,240.86 Million in 2019 to AUD 3,487.29 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the RNA Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Enabling Technologies is projected to witness the highest growth during the forecast period'
Based on Technology, the RNA Therapy Market studied across Enabled Technologies and Enabling Technologies. The Enabled Technologies further studied across Inhibition, Labeling, Linear amplification, Microarrays, Purification, and qRT-PCR. The Enabling Technologies further studied across RNA Antisense Technologies and RNA Interference Technologies. The Enabling Technologies commanded the largest size in the RNA Therapy Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.
'The Retinal Diseases is projected to witness the highest growth during the forecast period'
Based on Application, the RNA Therapy Market studied across Cancer, Cardiovascular, Genetic Disorders, Infectious Diseases, Kidney Diseases, Metabolic Disorders, Oncology, and Retinal Diseases. The Infectious Diseases commanded the largest size in the RNA Therapy Market in 2019. On the other hand, the Retinal Diseases is expected to grow at the fastest CAGR during the forecast period.
'The Diagnostics is projected to witness the highest growth during the forecast period'
Based on End User, the RNA Therapy Market studied across Academic Research, Diagnostics, and Drug Discovery & Development. The Drug Discovery & Development commanded the largest size in the RNA Therapy Market in 2019. On the other hand, the Diagnostics is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the RNA Therapy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the RNA Therapy Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global RNA Therapy Market including Alnylam Pharmaceuticals, Inc., Arbutus Biopharma Corporation, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals, Inc., Benitec Biopharma Limited, Biogen Inc., BioNTech SE, Cartesian Therapeutics, Inc., Cenix BioScience GmbH, Dicerna Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., MiNA Therapeutics Limited, Moderna, Inc., NeuBase Therapeutics, Inc., Nordic Nanovector ASA, ProQR Therapeutics N.V., Sanofi S.A., Silence Therapeutics PLC, Sirnaomics, Inc., Spark Therapeutics, Inc., and Triplet Therapeutics, Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the RNA Therapy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global RNA Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global RNA Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global RNA Therapy Market?
4. What is the competitive strategic window for opportunities in the Global RNA Therapy Market?
5. What are the technology trends and regulatory frameworks in the Global RNA Therapy Market?
6. What are the modes and strategic moves considered suitable for entering the Global RNA Therapy Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global RNA Therapy Market is expected to grow from USD 862.49 Million in 2019 to USD 2,401.50 Million by the end of 2025.
2. The Global RNA Therapy Market is expected to grow from EUR 770.10 Million in 2019 to EUR 2,105.68 Million by the end of 2025.
3. The Global RNA Therapy Market is expected to grow from GBP 675.89 Million in 2019 to GBP 1,871.95 Million by the end of 2025.
4. The Global RNA Therapy Market is expected to grow from JPY 94,018.26 Million in 2019 to JPY 256,300.90 Million by the end of 2025.
5. The Global RNA Therapy Market is expected to grow from AUD 1,240.86 Million in 2019 to AUD 3,487.29 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the RNA Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Enabling Technologies is projected to witness the highest growth during the forecast period'
Based on Technology, the RNA Therapy Market studied across Enabled Technologies and Enabling Technologies. The Enabled Technologies further studied across Inhibition, Labeling, Linear amplification, Microarrays, Purification, and qRT-PCR. The Enabling Technologies further studied across RNA Antisense Technologies and RNA Interference Technologies. The Enabling Technologies commanded the largest size in the RNA Therapy Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.
'The Retinal Diseases is projected to witness the highest growth during the forecast period'
Based on Application, the RNA Therapy Market studied across Cancer, Cardiovascular, Genetic Disorders, Infectious Diseases, Kidney Diseases, Metabolic Disorders, Oncology, and Retinal Diseases. The Infectious Diseases commanded the largest size in the RNA Therapy Market in 2019. On the other hand, the Retinal Diseases is expected to grow at the fastest CAGR during the forecast period.
'The Diagnostics is projected to witness the highest growth during the forecast period'
Based on End User, the RNA Therapy Market studied across Academic Research, Diagnostics, and Drug Discovery & Development. The Drug Discovery & Development commanded the largest size in the RNA Therapy Market in 2019. On the other hand, the Diagnostics is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the RNA Therapy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the RNA Therapy Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global RNA Therapy Market including Alnylam Pharmaceuticals, Inc., Arbutus Biopharma Corporation, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals, Inc., Benitec Biopharma Limited, Biogen Inc., BioNTech SE, Cartesian Therapeutics, Inc., Cenix BioScience GmbH, Dicerna Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., MiNA Therapeutics Limited, Moderna, Inc., NeuBase Therapeutics, Inc., Nordic Nanovector ASA, ProQR Therapeutics N.V., Sanofi S.A., Silence Therapeutics PLC, Sirnaomics, Inc., Spark Therapeutics, Inc., and Triplet Therapeutics, Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the RNA Therapy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global RNA Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global RNA Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global RNA Therapy Market?
4. What is the competitive strategic window for opportunities in the Global RNA Therapy Market?
5. What are the technology trends and regulatory frameworks in the Global RNA Therapy Market?
6. What are the modes and strategic moves considered suitable for entering the Global RNA Therapy Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Technology Outlook
3.4. Application Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Target specificity and selectivity of treatment and diagnostics
5.1.1.2. Strategic alliances & funding supported by pharmaceutical companies
5.1.1.3. Increased potential of virtual drug development models
5.1.2. Restraints
5.1.2.1. Hurdles in drug delivery commercialization
5.1.3. Opportunities
5.1.3.1. Increasing use in cell-based cancer immunotherapy
5.1.3.2. Significance of mRNA medicine to treat deficiency and genetic disorders
5.1.3.3. Pipelined clinical trials of RNA-based therapeutics
5.1.4. Challenges
5.1.4.1. Risk associated with investment & potential outcomes
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL RNA THERAPY MARKET, BY TECHNOLOGY
6.1. Introduction
6.2. Enabled Technologies
6.2.1. Inhibition
6.2.2. Labeling
6.2.3. Linear amplification
6.2.4. Microarrays
6.2.5. Purification
6.2.6. qRT-PCR
6.3. Enabling Technologies
6.3.1. RNA Antisense Technologies
6.3.1.1. MicroRNA
6.3.1.2. Small interfering RNA
6.3.2. RNA Interference Technologies
7. GLOBAL RNA THERAPY MARKET, BY APPLICATION
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular
7.4. Genetic Disorders
7.5. Infectious Diseases
7.6. Kidney Diseases
7.7. Metabolic Disorders
7.8. Oncology
7.9. Retinal Diseases
8. GLOBAL RNA THERAPY MARKET, BY END USER
8.1. Introduction
8.2. Academic Research
8.3. Diagnostics
8.4. Drug Discovery & Development
9. AMERICAS RNA THERAPY MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC RNA THERAPY MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Alnylam Pharmaceuticals, Inc.
13.2. Arbutus Biopharma Corporation
13.3. Arcturus Therapeutics Holdings Inc.
13.4. Arrowhead Pharmaceuticals, Inc.
13.5. Benitec Biopharma Limited
13.6. Biogen Inc.
13.7. BioNTech SE
13.8. Cartesian Therapeutics, Inc.
13.9. Cenix BioScience GmbH
13.10. Dicerna Pharmaceuticals, Inc.
13.11. Ionis Pharmaceuticals, Inc.
13.12. MiNA Therapeutics Limited
13.13. Moderna, Inc.
13.14. NeuBase Therapeutics, Inc.
13.15. Nordic Nanovector ASA
13.16. ProQR Therapeutics N.V.
13.17. Sanofi S.A.
13.18. Silence Therapeutics PLC
13.19. Sirnaomics, Inc.
13.20. Spark Therapeutics, Inc.
13.21. Triplet Therapeutics, Inc.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Technology Outlook
3.4. Application Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Target specificity and selectivity of treatment and diagnostics
5.1.1.2. Strategic alliances & funding supported by pharmaceutical companies
5.1.1.3. Increased potential of virtual drug development models
5.1.2. Restraints
5.1.2.1. Hurdles in drug delivery commercialization
5.1.3. Opportunities
5.1.3.1. Increasing use in cell-based cancer immunotherapy
5.1.3.2. Significance of mRNA medicine to treat deficiency and genetic disorders
5.1.3.3. Pipelined clinical trials of RNA-based therapeutics
5.1.4. Challenges
5.1.4.1. Risk associated with investment & potential outcomes
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL RNA THERAPY MARKET, BY TECHNOLOGY
6.1. Introduction
6.2. Enabled Technologies
6.2.1. Inhibition
6.2.2. Labeling
6.2.3. Linear amplification
6.2.4. Microarrays
6.2.5. Purification
6.2.6. qRT-PCR
6.3. Enabling Technologies
6.3.1. RNA Antisense Technologies
6.3.1.1. MicroRNA
6.3.1.2. Small interfering RNA
6.3.2. RNA Interference Technologies
7. GLOBAL RNA THERAPY MARKET, BY APPLICATION
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular
7.4. Genetic Disorders
7.5. Infectious Diseases
7.6. Kidney Diseases
7.7. Metabolic Disorders
7.8. Oncology
7.9. Retinal Diseases
8. GLOBAL RNA THERAPY MARKET, BY END USER
8.1. Introduction
8.2. Academic Research
8.3. Diagnostics
8.4. Drug Discovery & Development
9. AMERICAS RNA THERAPY MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC RNA THERAPY MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Alnylam Pharmaceuticals, Inc.
13.2. Arbutus Biopharma Corporation
13.3. Arcturus Therapeutics Holdings Inc.
13.4. Arrowhead Pharmaceuticals, Inc.
13.5. Benitec Biopharma Limited
13.6. Biogen Inc.
13.7. BioNTech SE
13.8. Cartesian Therapeutics, Inc.
13.9. Cenix BioScience GmbH
13.10. Dicerna Pharmaceuticals, Inc.
13.11. Ionis Pharmaceuticals, Inc.
13.12. MiNA Therapeutics Limited
13.13. Moderna, Inc.
13.14. NeuBase Therapeutics, Inc.
13.15. Nordic Nanovector ASA
13.16. ProQR Therapeutics N.V.
13.17. Sanofi S.A.
13.18. Silence Therapeutics PLC
13.19. Sirnaomics, Inc.
13.20. Spark Therapeutics, Inc.
13.21. Triplet Therapeutics, Inc.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL RNA THERAPY MARKET SIZE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL RNA THERAPY MARKET SIZE, BY INHIBITION, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL RNA THERAPY MARKET SIZE, BY LABELING, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL RNA THERAPY MARKET SIZE, BY LINEAR AMPLIFICATION, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL RNA THERAPY MARKET SIZE, BY MICROARRAYS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL RNA THERAPY MARKET SIZE, BY PURIFICATION, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL RNA THERAPY MARKET SIZE, BY QRT-PCR, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL RNA THERAPY MARKET SIZE, BY MICRORNA, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL RNA THERAPY MARKET SIZE, BY SMALL INTERFERING RNA, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL RNA THERAPY MARKET SIZE, BY RNA INTERFERENCE TECHNOLOGIES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL RNA THERAPY MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL RNA THERAPY MARKET SIZE, BY CARDIOVASCULAR, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL RNA THERAPY MARKET SIZE, BY GENETIC DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL RNA THERAPY MARKET SIZE, BY KIDNEY DISEASES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL RNA THERAPY MARKET SIZE, BY METABOLIC DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL RNA THERAPY MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL RNA THERAPY MARKET SIZE, BY RETINAL DISEASES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL RNA THERAPY MARKET SIZE, BY ACADEMIC RESEARCH, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL RNA THERAPY MARKET SIZE, BY DIAGNOSTICS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL RNA THERAPY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. AMERICAS RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AMERICAS RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AMERICAS RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. ARGENTINA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ARGENTINA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ARGENTINA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. BRAZIL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. BRAZIL RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. BRAZIL RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. CANADA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. CANADA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CANADA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MEXICO RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MEXICO RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. MEXICO RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. UNITED STATES RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. UNITED STATES RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. UNITED STATES RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. AUSTRALIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. AUSTRALIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. AUSTRALIA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. CHINA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. CHINA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. INDIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDIA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDONESIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDONESIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. JAPAN RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. JAPAN RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. JAPAN RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. MALAYSIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. MALAYSIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. MALAYSIA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. PHILIPPINES RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. PHILIPPINES RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. PHILIPPINES RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. SOUTH KOREA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. SOUTH KOREA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. SOUTH KOREA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. THAILAND RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. THAILAND RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. THAILAND RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. FRANCE RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. FRANCE RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. FRANCE RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. GERMANY RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. GERMANY RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. GERMANY RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. ITALY RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. ITALY RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. ITALY RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. NETHERLANDS RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. NETHERLANDS RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. NETHERLANDS RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. QATAR RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. QATAR RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. QATAR RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. RUSSIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. RUSSIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. RUSSIA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. SPAIN RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. SPAIN RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. SPAIN RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. GLOBAL RNA THERAPY MARKET: SCORES
TABLE 118. GLOBAL RNA THERAPY MARKET: BUSINESS STRATEGY
TABLE 119. GLOBAL RNA THERAPY MARKET: PRODUCT SATISFACTION
TABLE 120. GLOBAL RNA THERAPY MARKET: RANKING
TABLE 121. GLOBAL RNA THERAPY MARKET: MERGER & ACQUISITION
TABLE 122. GLOBAL RNA THERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 123. GLOBAL RNA THERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 124. GLOBAL RNA THERAPY MARKET: INVESTMENT & FUNDING
TABLE 125. GLOBAL RNA THERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 126. GLOBAL RNA THERAPY MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL RNA THERAPY MARKET SIZE, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL RNA THERAPY MARKET SIZE, BY INHIBITION, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL RNA THERAPY MARKET SIZE, BY LABELING, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL RNA THERAPY MARKET SIZE, BY LINEAR AMPLIFICATION, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL RNA THERAPY MARKET SIZE, BY MICROARRAYS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL RNA THERAPY MARKET SIZE, BY PURIFICATION, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL RNA THERAPY MARKET SIZE, BY QRT-PCR, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL RNA THERAPY MARKET SIZE, BY MICRORNA, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL RNA THERAPY MARKET SIZE, BY SMALL INTERFERING RNA, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL RNA THERAPY MARKET SIZE, BY RNA INTERFERENCE TECHNOLOGIES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL RNA THERAPY MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL RNA THERAPY MARKET SIZE, BY CARDIOVASCULAR, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL RNA THERAPY MARKET SIZE, BY GENETIC DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL RNA THERAPY MARKET SIZE, BY KIDNEY DISEASES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL RNA THERAPY MARKET SIZE, BY METABOLIC DISORDERS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL RNA THERAPY MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL RNA THERAPY MARKET SIZE, BY RETINAL DISEASES, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL RNA THERAPY MARKET SIZE, BY ACADEMIC RESEARCH, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL RNA THERAPY MARKET SIZE, BY DIAGNOSTICS, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL RNA THERAPY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. AMERICAS RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AMERICAS RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AMERICAS RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. ARGENTINA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ARGENTINA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ARGENTINA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. BRAZIL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. BRAZIL RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. BRAZIL RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. CANADA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. CANADA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CANADA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MEXICO RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MEXICO RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. MEXICO RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. UNITED STATES RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. UNITED STATES RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. UNITED STATES RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. AUSTRALIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. AUSTRALIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. AUSTRALIA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. CHINA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. CHINA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. INDIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDIA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDONESIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDONESIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. JAPAN RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. JAPAN RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. JAPAN RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. MALAYSIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. MALAYSIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. MALAYSIA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. PHILIPPINES RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. PHILIPPINES RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. PHILIPPINES RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. SOUTH KOREA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. SOUTH KOREA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. SOUTH KOREA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. THAILAND RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. THAILAND RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. THAILAND RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. FRANCE RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. FRANCE RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. FRANCE RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. GERMANY RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. GERMANY RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. GERMANY RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. ITALY RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. ITALY RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. ITALY RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. NETHERLANDS RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. NETHERLANDS RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. NETHERLANDS RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. QATAR RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. QATAR RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. QATAR RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. RUSSIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. RUSSIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. RUSSIA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. SPAIN RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. SPAIN RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. SPAIN RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY APPLICATION, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY END USER, 2017-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. GLOBAL RNA THERAPY MARKET: SCORES
TABLE 118. GLOBAL RNA THERAPY MARKET: BUSINESS STRATEGY
TABLE 119. GLOBAL RNA THERAPY MARKET: PRODUCT SATISFACTION
TABLE 120. GLOBAL RNA THERAPY MARKET: RANKING
TABLE 121. GLOBAL RNA THERAPY MARKET: MERGER & ACQUISITION
TABLE 122. GLOBAL RNA THERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 123. GLOBAL RNA THERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 124. GLOBAL RNA THERAPY MARKET: INVESTMENT & FUNDING
TABLE 125. GLOBAL RNA THERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 126. GLOBAL RNA THERAPY MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL RNA THERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL RNA THERAPY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL RNA THERAPY MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2019 (USD MILLION)
FIGURE 5. GLOBAL RNA THERAPY MARKET SIZE, BY APPLICATION, 2019 (USD MILLION)
FIGURE 6. GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2019 (USD MILLION)
FIGURE 7. GLOBAL RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
FIGURE 8. GLOBAL RNA THERAPY MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 9. GLOBAL RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 10. GLOBAL RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL RNA THERAPY MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL RNA THERAPY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (%)
FIGURE 15. GLOBAL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025
FIGURE 17. GLOBAL RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2019 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL RNA THERAPY MARKET SIZE, BY INHIBITION, 2019 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL RNA THERAPY MARKET SIZE, BY LABELING, 2019 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL RNA THERAPY MARKET SIZE, BY LINEAR AMPLIFICATION, 2019 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL RNA THERAPY MARKET SIZE, BY MICROARRAYS, 2019 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL RNA THERAPY MARKET SIZE, BY PURIFICATION, 2019 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL RNA THERAPY MARKET SIZE, BY QRT-PCR, 2019 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2019 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2019 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL RNA THERAPY MARKET SIZE, BY MICRORNA, 2019 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL RNA THERAPY MARKET SIZE, BY SMALL INTERFERING RNA, 2019 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL RNA THERAPY MARKET SIZE, BY RNA INTERFERENCE TECHNOLOGIES, 2019 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL RNA THERAPY MARKET SIZE, BY APPLICATION, 2019 VS 2025 (%)
FIGURE 30. GLOBAL RNA THERAPY MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA THERAPY MARKET SIZE, BY APPLICATION, 2025
FIGURE 32. GLOBAL RNA THERAPY MARKET SIZE, BY CANCER, 2019 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL RNA THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2019 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL RNA THERAPY MARKET SIZE, BY GENETIC DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2019 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL RNA THERAPY MARKET SIZE, BY KIDNEY DISEASES, 2019 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL RNA THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL RNA THERAPY MARKET SIZE, BY RETINAL DISEASES, 2019 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2019 VS 2025 (%)
FIGURE 41. GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2025
FIGURE 43. GLOBAL RNA THERAPY MARKET SIZE, BY ACADEMIC RESEARCH, 2019 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL RNA THERAPY MARKET SIZE, BY DIAGNOSTICS, 2019 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL RNA THERAPY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2019 VS 2025 (USD MILLION)
FIGURE 46. AMERICAS RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 47. AMERICAS RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. ARGENTINA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 50. BRAZIL RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 51. CANADA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 52. MEXICO RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 53. UNITED STATES RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 54. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 55. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 57. AUSTRALIA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 58. CHINA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 59. INDIA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 60. INDONESIA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 61. JAPAN RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 62. MALAYSIA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 63. PHILIPPINES RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 64. SOUTH KOREA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 65. THAILAND RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 68. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 69. FRANCE RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 70. GERMANY RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 71. ITALY RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 72. NETHERLANDS RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 73. QATAR RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 74. RUSSIA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 75. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 76. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 77. SPAIN RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 78. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 79. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 80. GLOBAL RNA THERAPY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 81. GLOBAL RNA THERAPY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 82. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RNA THERAPY MARKET, BY TYPE
FIGURE 1. GLOBAL RNA THERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL RNA THERAPY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL RNA THERAPY MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2019 (USD MILLION)
FIGURE 5. GLOBAL RNA THERAPY MARKET SIZE, BY APPLICATION, 2019 (USD MILLION)
FIGURE 6. GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2019 (USD MILLION)
FIGURE 7. GLOBAL RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
FIGURE 8. GLOBAL RNA THERAPY MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 9. GLOBAL RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 10. GLOBAL RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL RNA THERAPY MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL RNA THERAPY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (%)
FIGURE 15. GLOBAL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025
FIGURE 17. GLOBAL RNA THERAPY MARKET SIZE, BY ENABLED TECHNOLOGIES, 2019 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL RNA THERAPY MARKET SIZE, BY INHIBITION, 2019 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL RNA THERAPY MARKET SIZE, BY LABELING, 2019 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL RNA THERAPY MARKET SIZE, BY LINEAR AMPLIFICATION, 2019 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL RNA THERAPY MARKET SIZE, BY MICROARRAYS, 2019 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL RNA THERAPY MARKET SIZE, BY PURIFICATION, 2019 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL RNA THERAPY MARKET SIZE, BY QRT-PCR, 2019 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL RNA THERAPY MARKET SIZE, BY ENABLING TECHNOLOGIES, 2019 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL RNA THERAPY MARKET SIZE, BY RNA ANTISENSE TECHNOLOGIES, 2019 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL RNA THERAPY MARKET SIZE, BY MICRORNA, 2019 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL RNA THERAPY MARKET SIZE, BY SMALL INTERFERING RNA, 2019 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL RNA THERAPY MARKET SIZE, BY RNA INTERFERENCE TECHNOLOGIES, 2019 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL RNA THERAPY MARKET SIZE, BY APPLICATION, 2019 VS 2025 (%)
FIGURE 30. GLOBAL RNA THERAPY MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA THERAPY MARKET SIZE, BY APPLICATION, 2025
FIGURE 32. GLOBAL RNA THERAPY MARKET SIZE, BY CANCER, 2019 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL RNA THERAPY MARKET SIZE, BY CARDIOVASCULAR, 2019 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL RNA THERAPY MARKET SIZE, BY GENETIC DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL RNA THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2019 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL RNA THERAPY MARKET SIZE, BY KIDNEY DISEASES, 2019 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL RNA THERAPY MARKET SIZE, BY METABOLIC DISORDERS, 2019 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL RNA THERAPY MARKET SIZE, BY ONCOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL RNA THERAPY MARKET SIZE, BY RETINAL DISEASES, 2019 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2019 VS 2025 (%)
FIGURE 41. GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RNA THERAPY MARKET SIZE, BY END USER, 2025
FIGURE 43. GLOBAL RNA THERAPY MARKET SIZE, BY ACADEMIC RESEARCH, 2019 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL RNA THERAPY MARKET SIZE, BY DIAGNOSTICS, 2019 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL RNA THERAPY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2019 VS 2025 (USD MILLION)
FIGURE 46. AMERICAS RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 47. AMERICAS RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. ARGENTINA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 50. BRAZIL RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 51. CANADA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 52. MEXICO RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 53. UNITED STATES RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 54. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 55. ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 57. AUSTRALIA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 58. CHINA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 59. INDIA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 60. INDONESIA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 61. JAPAN RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 62. MALAYSIA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 63. PHILIPPINES RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 64. SOUTH KOREA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 65. THAILAND RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 68. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 69. FRANCE RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 70. GERMANY RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 71. ITALY RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 72. NETHERLANDS RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 73. QATAR RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 74. RUSSIA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 75. SAUDI ARABIA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 76. SOUTH AFRICA RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 77. SPAIN RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 78. UNITED ARAB EMIRATES RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 79. UNITED KINGDOM RNA THERAPY MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 80. GLOBAL RNA THERAPY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 81. GLOBAL RNA THERAPY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 82. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RNA THERAPY MARKET, BY TYPE
